James McArthur is the founder of Pepgen. Pepgen has raised $234M in total funding. Latest round: Series A. Based in Cambridge, Massachusetts.
James McArthur, Ph.D., is the Co-founder and CEO of PepGen, a biotechnology company focused on enhanced delivery oligonucleotide (EDO) therapies for genetic diseases such as Duchenne muscular dystrophy. He joined PepGen as CEO in January 2021 after contributing to early development work prior to the company's Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library